Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset

View ORCID ProfileAmy Lynn Baxter, View ORCID ProfileKyle R. Schwartz, Ryan W. Johnson, View ORCID ProfileArni S. R. Srinivasa Rao, View ORCID ProfileRobert W. Gibson, Erica Cherian, Ann-Marie Kuchinski, View ORCID ProfileMatthew Lyon, Richard Schwartz
doi: https://doi.org/10.1101/2021.08.16.21262044
Amy Lynn Baxter
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy Lynn Baxter
  • For correspondence: abaxter{at}augusta.edu
Kyle R. Schwartz
2Edinburgh Napier University, Sighthill Court, Edinburgh EH11 4BN
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kyle R. Schwartz
Ryan W. Johnson
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
MPH MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arni S. R. Srinivasa Rao
3Laboratory for Theory and Mathematical Modeling, Department of Medicine-Division of Infectious Diseases, Medical College of Georgia, Augusta University
4Department of Mathematics, Augusta University, 1120 15th Street, AE2040, Augusta, GA 30912
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arni S. R. Srinivasa Rao
Robert W. Gibson
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
PhD, MSOTR/L FAOTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert W. Gibson
Erica Cherian
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann-Marie Kuchinski
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Lyon
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew Lyon
Richard Schwartz
1Dept. Emergency Medicine, Augusta University, 1120 15th Street, AF-1024 Augusta, GA 30912
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To determine whether nasal irrigation initiated within 24 hours of a positive PCR test result reduces hospitalizations for COVID-19.

Design, Setting and Participants Prospective case:cohort trial comparing clinical outcomes in patients aged 55 years or older who were PCR positive at a community testing site in Augusta, Georgia. Patients randomized to initiate one of two nasal irrigation regimens were compared to outcomes in the CDC national database from September 23 to December 21, 2020 with follow up until January 18.

nterventions Participants were assigned on alternate days to one of two pressure-based nasal irrigation systems (NAVAGE, Rhinosystems Inc.) or Neilmed Sinus Rinse (Neilmed Inc.), and randomized to include 2.5ml povidone-iodine 10% (antimicrobial) or 0.5 teaspoon sodium bicarbonate (alkalinization) to the standard saline rinse twice daily for 14 days with 14 day follow-up.

Main Outcomes and Measures The primary outcome was hospitalization for COVID-19 symptoms within 28 days of enrollment by daily self-report confirmed with phone follow up and hospital records compared to hospitalization rates publicly available from the CDC. Secondary outcomes in enrolled patients compared symptom resolution and home exposure, adherence to nasal irrigation, and any impact of irrigation system or antimicrobial or alkalization addition to the irrigant.

Results Of 79 patients assigned to nasal irrigation (63.99[7.96] years, 36[45.6%] female, 43[54.4%]male), 0/37 assigned to povidone-iodine and 1/42 patients in the alkalinization group had a COVID-19 related hospitalization (1.26%). From September 22 to December 21, 2020, in patients 50+ years the CDC reported 1022977 cases with 197777 hospitalizations, or 19.33% (OR:0.054, 95%CI0.0074 to 0.38, p=0.0036). Diaries were completed by 62 patients, averaging 1.79 irrigations/day. There were no statistical differences in outcomes by irrigation unit used, of those with symptoms, resolution was more likely in the povidone-iodine group (19/25) than the alkalinization group (15/33, OR.26 (95%CI 0.084 to 0.83,p=0.022).

Conclusion Patients who initiated isotonic saline nasal irrigation after a positive COVID-19 PCR test were 19 times less likely to be hospitalized than the national rate. Further research is required to determine if adding povidone-iodine to irrigation reduces morbidity and mortality of SARS-CoV-2 infection.

Trial Registration ClinicalTrial.gov Identifier: NCT04559035

Competing Interest Statement

After obtaining permission from the Augusta University Department of Emergency Medicine to pursue funding for the study, I reached out to Georgia and national nonprofits. I was able to get the Community Foundation for Greater Atlanta to provide $10,000, and Rhinosystems Inc to provide NAVAGE units and NeilMed Inc. to provide Sinus Rinse units for the study As I was unable to raise more funding, I went back to Rhinosystems Inc. and NeilMed Inc. who each matched the Community Foundation for Greater Atlanta with $10,000 in unrestricted funds to the National Disaster Life Support Foundation. All physicians and research staff contributed their time pro bono. Neither I nor any of the authors nor Augusta University have prior or ongoing relationships with either Sinus Rinse company. Any hourly staff were compensated by the nonprofit.

Clinical Trial

NCT04559035

Funding Statement

Nasal irrigation systems were provided by Rhinosystems Inc. and Neilmed Inc. For additional materials, patient compensation, and study enrollers The Bernard and Anne Gray Donor Advised Fund Community Foundation for Greater Atlanta, Neilmed Inc., and Rhinosystems Inc. each donated $10,000 in unrestricted funds to the National Disaster Life Support Foundation who supported the study. No authors received external funding or have any prior or ongoing economic relationship with any donors.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board Office Augusta University 1120 15th St., CJ-2103 Augusta GA 30912-7621 Email: IRB{at}augusta.edu Phone: 706-721-3110 http://www.augusta.edu/research/irboffice/

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available from the University of Augusta Department of Emergency Medicine Research Office, and online from the CDC COVID-19 Case Surveillance Public Use Data

https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Public-Use-Data/vbim-akqf/data

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 17, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset
Amy Lynn Baxter, Kyle R. Schwartz, Ryan W. Johnson, Arni S. R. Srinivasa Rao, Robert W. Gibson, Erica Cherian, Ann-Marie Kuchinski, Matthew Lyon, Richard Schwartz
medRxiv 2021.08.16.21262044; doi: https://doi.org/10.1101/2021.08.16.21262044
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Rapid initiation of nasal saline irrigation: hospitalizations in COVID-19 patients randomized to alkalinization or povidone-iodine compared to a national dataset
Amy Lynn Baxter, Kyle R. Schwartz, Ryan W. Johnson, Arni S. R. Srinivasa Rao, Robert W. Gibson, Erica Cherian, Ann-Marie Kuchinski, Matthew Lyon, Richard Schwartz
medRxiv 2021.08.16.21262044; doi: https://doi.org/10.1101/2021.08.16.21262044

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)